论文信息 - Pembrolizumab combined with lenalidomide and low‐dose dexamethasone for relapsed or refractory multiple myeloma: phase I KEYNOTE‐023 study - 字舞流文

Pembrolizumab combined with lenalidomide and low‐dose dexamethasone for relapsed or refractory multiple myeloma: phase I KEYNOTE‐023 study

D. Siegel | N. Munshi | D. Reece | R. Orlowski | P. Moreau | E. Ocio | J. San-Miguel | M. Mateos | D. Avigan | M. Farooqui | P. Marinello | R. Ghori | P. Rodríguez-Otero